IMMERSION CORP - Common Stock, $0.001 par value (IMMR)

CUSIP: 452521107

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 7 signals
Share change
-300,543
Put/Call ratio
104%
SEC-reported price per share
$5.49
Number of holders
80
Value change
-$1,576,662
Number of buys
33
Open additional details 1 more signal available
Number of sells
49
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
33,217,473

Security key

452521107

Report period

Q3 2022

Institutions

80

Top holders

10

Ownership snapshot

Top reported holders of IMMR - IMMERSION CORP - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Invenomic Capital Managem...
Disclosed value leader
Invenomic Capital Managem...
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F Highest disclosed value: $8,913,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Invenomic Capital Management LP has the largest disclosed position value at $8.91M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Invenomic Capital Management LP's linked filing trail.
Disclosed position value Top 5
Invenomic Capital Management LP $8.91M
VANGUARD GROUP INC $7.49M
Portolan Capital Management, LLC $7.49M
ROYCE & ASSOCIATES LP $6.05M
JACOB ASSET MANAGEMENT OF NEW YOR... $4.1M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Invenomic Capital Management LP
13F
Company
13F
—
denominator unverified
$8,913,000
1,669,161 shares
— 30 Jun 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$7,491,000
1,402,695 shares
— 30 Jun 2022
Portolan Capital Management, LLC
13F
Company
13F
—
denominator unverified
$7,486,000
1,401,884 shares
— 30 Jun 2022
ROYCE & ASSOCIATES LP
13F
Company
13F
—
denominator unverified
$6,048,000
1,132,523 shares
— 30 Jun 2022
JACOB ASSET MANAGEMENT OF NEW YORK LLC
13F
Company
13F
—
denominator unverified
$4,101,000
768,059 shares
— 30 Jun 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$2,892,000
541,706 shares
— 30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
80
Shares
14,469,623
Rows available
80
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
87
Q3 2022 holders
80
Holder diff
-7
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .